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Cytosolic DNA Sensor Upregulation Accompanies
DNA Electrotransfer in B16.F10 Melanoma Cells
Katarina Znidar1, Masa Bosnjak2, Maja Cemazar1,2 and Loree C. Heller3,4

In several preclinical tumor models, antitumor effects occur after intratumoral electroporation, also known as electrotransfer,
of plasmid DNA devoid of a therapeutic gene. In mouse melanomas, these effects are preceded by significant elevation of
several proinflammatory cytokines. These observations implicate the binding and activation of intracellular DNA-specific
pattern recognition receptors or DNA sensors in response to DNA electrotransfer. In tumors, IFNβ mRNA and protein levels
significantly increased. The mRNAs of several DNA sensors were detected, and DAI, DDX60, and p204 tended to be upregulated.
These effects were accompanied with reduced tumor growth and increased tumor necrosis. In B16.F10 cells in culture, IFNβ
mRNA and protein levels were significantly upregulated. The mRNAs for several DNA sensors were present in these cells; DNAdependent activator of interferon regulatory factor (DAI), DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (DDX60), and p204 were
significantly upregulated while DDX60 protein levels were coordinately upregulated. Upregulation of DNA sensors in tumors
could be masked by the lower transfection efficiency compared to in vitro or to dilution by other tumor cell types. Mirroring
the observation of tumor necrosis, cells underwent a significant DNA concentration-dependent decrease in proliferation and
survival. Taken together, these results indicate that DNA electrotransfer may cause the upregulation of several intracellular
DNA sensors in B16.F10 cells, inducing effects in vitro and potentially in vivo.
Molecular Therapy—Nucleic Acids (2016) 5, e322; doi:10.1038/mtna.2016.34; published online 7 June 2016
Subject Category: Mechanisms of gene and nucleic acid transfer/transfection | Vector trafficking and biodistribution
Introduction
In vivo electroporation or electrotransfer, the application of
controlled electric pulses, enhances delivery of plasmid DNA
(pDNA) to a wide variety of healthy tissues as well as many
tumor types.1–4 Electrotransfer of pDNA encoding therapeutic
genes substantially increases gene expression, enhancing
subsequent therapeutic effects. This gene delivery technique
has reached clinical trials for cancer therapies, cancer vaccines, and infectious disease vaccines.5
In studies of cancer therapies in preclinical models, several
groups have observed inhibition of tumor growth, increased
survival time, and complete tumor regression after intratumor electrotransfer of oligonucleotides, plasmids devoid of
encoded therapeutic genes, or plasmids encoding reporter
genes. Antitumor effects have been described in melanomas,6–12 lung carcinomas,13,14 fibrosarcomas,15 pancreatic carcinomas,16 mammary tumors,17 and colorectal carcinomas.18–21
After electrotransfer of pDNA devoid of a therapeutic gene,
increased expression of several proinflammatory cytokine and
chemokine proteins, particularly CCL3, CCL4, IL-1β, and IL-6,
was observed in B16.F10 melanoma tumors and preceded
tumor regression.10 Subsequent tumor-localized inflammation
might contribute to the observed tumor regression.7,11
During the process of electrotransfer, pDNA theoretically enters the cell via endocytosis.22,23 This theory was

supported in vivo by the observation that the inhibition
of endocytosis also inhibits gene expression in skeletal
muscle.24 The observations that DNA enters cell via endocytosis during electrotransfer and that proinflammatory
molecule expression was upregulated implicated the activation of the endosomal CpG motif DNA binding receptor toll-like receptor 9 (TLR9).25 However, regression was
induced by electrotransfer of calf thymus DNA or non-CpG
containing control oligonucleotides,11 which are not classic
TLR9 ligands.
Electrotransfer also delivers pDNA to the cytosol, which
is probably a dead-end pathway with respect to transgene
expression.26,27 The presence and activity of several DNAspecific cytosolic pattern recognition receptors, also known
as DNA sensors, has been demonstrated in a variety of cell
types, including fibroblasts, tumor cells, and immune cells.28–31
pDNA electrotransfer may enhance the availability of pDNA
to cytosolic DNA sensor binding, inducing the production
of proinflammatory cytokine and chemokines, particularly
type I interferons.28,29,31 Therefore, all cell types residing in
the tumor could potentially respond to pDNA electrotransfer.
However, the tumor cells themselves are universally present.
The purpose of this study was to investigate whether B16.
F10 mouse melanoma tumors and cells express cytosolic
DNA sensors and whether these sensors respond to pDNA
electrotransfer.
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Results
Tumor growth delay and complete tumor regression
induced by pDNA electrotransfer of empty vector plasmid
is preceded by increased expression of interferon-β
A single intratumor pDNA delivery by electrotransfer produced
a significant growth delay in treated tumors (Figure 1a). In this
experimental group, doubling time was decreased 3.2-fold;
tripling time was decreased 2.8-fold. In addition, pDNA electrotransfer induced complete tumor regression in 1 out of
10 mice (Figure 1a). Hematoxylin & eosin (H&E) staining of
tumor sections 6, 20, and 36 hours after pDNA electrotransfer demonstrated a statistically significant increased proportion
of necrosis after pDNA electrotransfer at all three time points
compared to pDNA injection alone, electrotransfer alone, and in
unmanipulated control tumors. The control tumors had approximately 4–6% necrosis, while the proportion of necrosis in the
experimental groups increased with time (Figure 1b,e) and
reached 84% 20 hours after pDNA electrotransfer. The presence of inflammatory immune cells was observed at the tumor
borders in the pDNA electrotransfer group (Supplementary
Figure S1). Due to the early onset of necrotic cell death, the
proportion of apoptotic cells as indicated by cleaved caspase
3 was evaluated at 6 hours after pDNA electrotransfer. No statistically significant difference in proportion of apoptotic cells
between the groups was observed. At 6 hours post-treatment,
necrosis was evenly distributed throughout the tumor tissue
and no clear sharp boundary was observed between necrotic
and apoptotic areas and viable tissue (Figure 1e). These
results indicate that necrosis is more likely to occur after pDNA
electrotransfer than apoptosis.
Interferon-β (IFNβ) is a marker of cytosolic DNA sensor activation.32–40 The effect of pDNA electrotransfer on intratumoral
IFNβ mRNA and protein levels in tumors was determined.
Real-time reverse transcriptase polymerase chain reaction
(RT-PCR) demonstrated that while no change in IFNβ mRNA
levels was detected in control tumors, tumors injected with
pDNA, or tumors subjected to electrotransfer alone, the combination of pDNA and electrotransfer produced an increase
of approximately 13-fold (P < 0.05) (Figure 1c). IFNβ protein
levels correlated with the mRNA levels ( Figure 1d); an 11-fold
increase was observed only in the tumors subjected to the
combination of pDNA injection and electrotransfer (P < 0.01).
Tumor mRNA levels for several DNA sensors were determined by real-time RT-PCR 4 hours after the procedure
(Table 1). While the all mRNAs tested except RIG-1 (retinoic
acid inducible gene upregulation of type I interferon) and
p202 were detected in the tumors, none were significantly
upregulated in any experimental group. Either pDNA injection
or pDNA electrotransfer tended to increase DDX60 (DEAD
(Asp-Glu-Ala-Asp) box polypeptide 60) levels, while pDNA
electrotransfer alone tended to increase DAI (DNA-dependent activator of interferon regulator factors) and p204 mRNA
levels. Notably, the mRNA levels for the endosomal DNA sensor TLR9 did not change.
pDNA electrotransfer directly effects B16.F10 melanoma
cells
In vitro experiments were performed to determine if IFNβ was
produced by B16.F10 cells subjected to pDNA electrotransfer. An increase in IFNβ mRNA of nearly 60-fold (P < 0.01)
Molecular Therapy—Nucleic Acids

was detected in cells subjected to pDNA electrotransfer when
compared to pDNA exposure alone, electrotransfer alone,
and unmanipulated control cells (Figure 2a). This observation was supported by a fivefold increase in IFNβ promoter
activation as measured by a reporter assay (Figure 2b,
P < 0.05), indicating that transcriptional upregulation may be
partially responsible. A significant increase in IFNβ protein
levels was detected in B16.F10 cells by enzyme-linked immunosorbent assay (ELISA) (Figure 2c, P < 0.01). Flow cytometry demonstrated that the number of cells expressing IFNβ
protein increased nearly sixfold (Figure 2d, P < 0.01) with
an increase in median fluorescent intensity of nearly 10-fold
(Figure 2e, P < 0.01) after pDNA electrotransfer.
DNA sensor mRNA levels in B16.F10 cells were determined
(Table 2). The mRNAs for TLR9 and AIM2 (absent in melanoma 2) were not detected. TLR9 is expressed in immune
cells, while AIM2 is not normally expressed in melanoma
cells. As with B16.F10 tumors, RIG-1 and p202 mRNAs were
not detected. Interestingly, mRNAs for cGAS (cyclic guanosine monophosphate-adenosine monophosphate synthase),
DDX41 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 41), and
LRRFIP1 (leucine-rich repeat flightless-interacting protein 1)
as well as the CpG motif-specific sensors DHX9 (DexD/Hbox helicase family 9) and DHX36 (DexD/H-box helicase
family 36) were detected, although they were not upregulated
in any group. The mRNAs of three cytosolic DNA sensors
significantly increased after pDNA electrotransfer in B16.
F10 cells. DAI mRNA was upregulated by approximately 355fold, DDX60 mRNA was upregulated by more than 6-fold,
and p204 mRNA was upregulated by approximately 18-fold.
Upregulation of cytosolic DNA sensors after pDNA electrotransfer was confirmed using a different electroporation protocol (EP1). After EP1, similar mRNAs were upregulated as
shown in Table 2. Although these pulse protocols demonstrated similar transfection efficiencies (Figure 3b), different
levels of upregulation of DAI (P < 0.001) and p204 (P < 0.01)
mRNAs were detected. Therefore, transfection efficiency
may not relate to DNA sensor upregulation. Furthermore,
the upregulation of cytosolic DNA sensors was confirmed
also with an alternate plasmid, pEGFP-N1, which encodes
enhanced GFP (pEGFP-N1) in another backbone. Electrotransfer of pEGFP-N1 resulted in DDX60 mRNA upregulation
by 3.98 ± 1.15, DAI mRNA by 7.88 ± 0.15, and p204 mRNA by
4.46 ± 3.18-fold.
An increase in DDX60 protein detected by two methods
confirmed the mRNA results. A sevenfold increase in cells
expressing DDX60 (Figure 2f, P < 0.05) and a 10-fold
increase in the median fluorescent intensity in these cells
was detected by flow cytometric after pDNA electrotransfer
(Figure 2g, P < 0.05). On western blots, the DDX60 protein
was detected in cell lysate only after pDNA electrotransfer
as predicted by the 198 kDa band. No DDX60 protein was
detected in any other experimental group (Figure 2h).
We next determined if pDNA electrotransfer using different
protocols had a direct effect on melanoma cell survival. The
exposure of cells to pDNA had no effect on cell survival, while
the application of electric pulses alone decreased viability by
80% after EP and 30% after EP1 72 hours post-treatment.
A significant pDNA concentration-dependent decrease in cell
survival was observed after pDNA electrotransfer using both
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Figure 1 Effect of pDNA electrotransfer on tumor growth, necrosis, and expression of IFNβ. Commercially prepared vector plasmid
(gWiz Blank) was electrotransferred into palpable B16.F10 melanoma tumors in the flanks of C57Bl/6 mice. Control, no tumor manipulation;
EP, 50 μl saline injection followed by the delivery of eight 5 ms pulses with a voltage-to-distance ratio of 800 V/cm with a caliper electrode;
pDNA, injection of 50 μl 2 mg/ml gWiz Blank plasmid; EP+pDNA, injection of 50 μl 2 mg/ml gWiz Blank plasmid followed by the delivery of eight
5 ms pulses with a voltage-to-distance ratio of 800 V/cm with a caliper electrode. (a) Tumor growth was monitored as described. A complete
response (CR, EP+pDNA CR) was observed in 1 out of 10 mice. Results represent two independent experiments, n = 5 for each experimental
group in each experiment, and are expressed as mean ± SEM. (b) Necrosis was significantly increased in EP+pDNA group at all three time
points compared to all other experimental groups. *P < 0.05 statistically significantly increased necrosis. (c) IFNβ mRNA levels as measured
by real-time RT-PCR, n = 7–8. (d) IFNβ protein levels as measured by ELISA, n = 5–7. (e) Comparison of cleaved caspase-3 and hematoxylin
& eosin staining of representative tumors sections 6 hours after pDNA electrotransfer. Results indicating that necrosis is more likely to occur
after pDNA electrotransfer than apoptosis. Representative images, red scale bar = 1 mm and black scale bar = 50 µm.

protocols (Figure 3a, P < 0.01); however, the decrease of
survival after EP1 was smaller than after EP. The transfection
efficiency with these electroporation protocols was identical
(Figure 3b).
The mechanisms of cell death were investigated in vitro to
confirm our previous findings in vivo. Using a flow cytometric
assay, relative changes in annexin V and 7AAD detection are
characteristic of apoptotic or necrotic cell death. Electrotransfer of pDNA with EP pulses caused necrotic cell death as indicated by a higher percentage of annexin V and 7AAD-positive
cells (Supplementary Figure S2), while apoptosis after pDNA
electrotransfer with these pulses was not increased as indicated by no change in percentage of cells positive for annexin
V (Supplementary Figure S2). In contrast, electrotransfer
of pDNA with EP1 pulses caused predominantly apoptosis,

while necrosis was also increased (Figure 3c). These findings
indicate that not only plasmid DNA but also pulse parameters
are responsible for triggering cell death mechanisms. Moreover, morphological changes confirmed the flow cytometry
data; necrosis as well as apoptosis were clearly seen after
pDNA electrotransfer (Figure 3d).
Theoretically, the inhibition of endocytosis could modulate DNA sensor upregulation. As expected, exposure to
the general inhibitor of endocytosis MβCD reduced transgene expression from approximately 30% of cells to 3% with
reduced fluorescent intensity. MβCD pretreatment increased
the levels of DDX60 and IFNβ mRNAs approximately twofold
after pDNA electrotransfer (P < 0.05, P < 0.01 respectively),
whereas DAI mRNA levels strongly decreased (Tables 2 and 3)
(P < 0.05). TLR9 mRNA remained undetectable.
www.moleculartherapy.org/mtna
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Table 1 Fold changes in mRNA levels of DNA sensors in B16.F10 tumors four hours after pDNA electrotransfer
Control

N

EP

N

pDNA

N

EP+pDNA

N

AIM2

1.08 ± 0.26

3

0.46 ± 0.12

3

1.24 ± 0.61

5

1.34 ± 0.28

5

cGAS

1.09 ± 0.33

3

0.56 ± 0.09

3

0.95 ± 0.20

5

2.09 ± 0.47

5

DAI

1.26 ± 0.50

3

0.58 ± 0.43

3

1.84 ± 0.08

5

2.93 ± 0.66

5

DDX41

1.11 ± 0.35

3

0.91 ± 0.21

3

1.66 ± 0.50

5

2.07 ± 0.65

5

DDX60

1.27 ± 0.24

11

0.82 ± 0.37

10

3.07 ± 1.24

12

4.74 ± 1.28

13

DHX9

1.04 ± 0.20

3

0.80 ± 0.07

3

1.01 ± 0.14

5

1.07 ± 0.09

5

DHX36

1.00 ± 0.02

3

0.79 ± 0.07

3

0.93 ± 0.11

5

1.08 ± 0.06

5

p202

ND

3

ND

3

ND

5

ND

5

p204

1.02 ± 0.14

3

0.47 ± 0.22

3

1.52 ± 0.41

5

3.82 ± 1.06

5

LRRFIP1

1.03 ± 0.17

3

0.84 ± 0.04

3

1.26 ± 0.40

5

0.97 ± 0.10

5

RIG-1

ND

3

ND

3

ND

5

ND

5

TLR9

1.07 ± 0.29

3

0.43 ± 0.18

3

1.35 ± 0.68

5

2.08 ± 0.46

5

Sensora

Control, no tumor manipulation; EP, 50 µl saline injection followed by the delivery of eight 5 ms pulses with a voltage-to-distance ratio of 800 V/cm and frequency 1 Hz with a caliper electrode; pDNA, injection of 50 µl 2 mg/ml gWiz Blank plasmid; EP+pDNA, injection of 50 µl 2 mg/ml gWiz Blank plasmid followed
by the delivery of eight 5 ms pulses with a voltage-to-distance ratio of 800 V/cm and frequency 1 Hz with a caliper electrode.
a
AIM2, absent in melanoma 2 (refs. 63–65); cGAS, cyclic guanosine monophosphate-adenosine monophosphate synthase40; DAI, DNA-dependent a
 ctivator
of interferon regulatory factor32; DDX41, DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 (ref. 34); DDX60, DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 (ref. 35);
DHX9, DEAH (Asp-Glu-Ala-His) box helicase 9 (ref. 66); DHX36, DEAH (Asp-Glu-Ala-His) box helicase 36 (ref. 66); p202 (ref. 67); p204 (ref. 33); LRRFIP1;
leucine-rich repeat flightless-interacting protein 1 (ref. 68); RIG-1, retinoic acid inducible gene upregulation of Type I interferon; TLR9, toll-like receptor 9
(ref. 25). Mean ± SEM.
ND, not detected.

Discussion
The results of our study demonstrate that B16.F10 melanoma
tumors secrete IFNβ after electrotransfer of pDNA (plasmid
devoid of therapeutic genes) and that necrosis is produced.
B16.F10 cells in culture express cytosolic DNA sensors and
the expression of DAI, DDX60 and p204 mRNAs, DDX60
protein, and IFNβ m RNA and protein are increased after
pDNA electrotransfer. These changes in mRNA and protein
levels are accompanied by DNA concentration-dependent
cell death. These effects may be due to the activation of signaling pathways mediated by the upregulated cytosolic DNA
sensors.
In this study, a reproducible negative effect on tumor growth
was observed using vector pDNA electrotransfer, confirming previous studies with other pulse protocols.6–21 However,
while some tumor regression was observed, in this case the
effect manifested itself primarily as a tumor growth delay
(Figure 1), which is consistent with the histological observation that 16% of the tumor cells in vivo and 20% in vitro may
retain viability. Although the identical plasmid (gWiz Blank)
produced a higher level of complete regressions in a previous
study,11 the decreased antitumor effect observed in this study
may be due to the differences between the electroporation
protocols employed.
Some unknown characteristic of the DNA composition is
an important variable in this antitumor effect. Using a similar pulse protocol (ten 5 ms pulses at a voltage-to-distance
ratio of 800 V/cm), three deliveries of pUC18 in 1 week produced complete, long-term regression in 70% of mice,7 while
three deliveries of gWiz Blank produced complete, long-term
regression in only 25% of mice.11 Delivery of calf thymus DNA
with the same pulse protocol induces regression in 15% of
tumors.11 Clearly, the composition of the DNA itself is an
important variable.

Molecular Therapy—Nucleic Acids

This antitumor effect was independent of caspase-3
and tumor necrosis was observed in the treated tumors
(Figure 1b,c). A direct cytotoxic effect against melanoma
cells subjected to pDNA electrotransfer in culture was also
demonstrated (Figure 3a). Here, the mechanism of cell death
was predominantly necrosis as observed in tumors in vivo.
Interestingly, the apoptotic cell death of melanoma cells in
culture was increased after EP1, which was also described
previously in tumors in vivo.41 The level of cell death did not
correlate with the transfection efficiency. Although these two
electroporation protocols produced similar levels of transgene
expression (Figure 3b), subsequent cell death varied greatly
(Figure 3a). Therefore, it seems that besides the composition
of the DNA itself, the electrical parameters contribute to the
mechanism of cell death following the pDNA electrotransfer.
After pDNA electrotransfer, increased mRNA levels of several cytosolic DNA sensors associated with cell death were
observed. For example, DAI is essential for programmed
necrosis after murine cytomegalovirus infection.42 IFI16, the
human ortholog of p204, is associated with p53-mediated
apoptosis43 and caspase-1-dependent pyroptosis after CD4
cells are exposed to HIV-1 transcripts.44 Activation of DNA
sensors associated with electrotransfer may cause cell death.
In this study, we found that the mRNA of the proinflammatory molecule IFNβ was significantly upregulated in B16.F10
tumors subjected to pDNA electrotransfer (Figure 1c). Many
putative intracellular DNA sensors inducing IFNβ expression
have been described, and one of these, an unknown sensor, or an unrelated mechanism might be responsible for
the observed inflammatory protein production.28–31 While the
mRNAs of several cytosolic sensors and the endosomal sensor TLR9 remained unchanged, the mRNAs of the cytosolic
DNA sensors DDX60, p204, and DAI tended to be upregulated in tumors after pDNA electrotransfer (Table 2). The low
transfection efficiency may have masked more pronounced
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Figure 2 Levels of IFNβ and DDX-60 mRNA and protein after pDNA electrotransfer in B16.F10 mouse melanoma cells. (a) IFNβ
mRNA levels as measured by real-time RT-PCR, n = 5–9. (b) IFNβ promotor activity as measured by luciferase expression, n = 4. (c) IFNβ
protein levels as measured by ELISA, n = 3. (d) Fold cells positive for IFNβ as measured by flow cytometry normalized to the control, n = 6–8.
(e) Median IFNβ fluorescent intensity as measured by flow cytometry normalized to the control, n = 6–8. (f) Fold cells positive for DDX60
as measured by flow cytometry normalized to the control, n = 7. (g) Median DDX60 fluorescent intensity as measured by flow cytometry
normalized to the control, n = 7. (h) Western blot of cell lysate demonstrating an increased expression of DDX60 9 hours after pDNA
electrotransfer. Control, 40 µl of cells and 10 µl of saline; EP, 40 µl of cells and 10 µl of saline were electroporated by the delivery of eight
5 ms pulses with a voltage-to-distance ratio of 600 V/cm with a plate electrode; pDNA, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid;
EP+pDNA, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid were lectroporated by the delivery of eight 5 ms pulses with a voltage-todistance ratio of 600 V/cm with a plate electrode.

responses, although we demonstrate in vitro that pulse protocols with similar transfection efficiencies (Figure 3b) can
correlate to different levels of DNA sensor mRNA upregulation (Table 2). Using similar electrotransfer parameters, more
than 50% of B16F1 cells were transfected in vitro, while only
3% of tumor area was transfected in vivo.45 Another possibility is that this upregulation is masked by the inherent cellular heterogeneity of tumors. All nucleated cells can respond
to type I interferons46,47 and both IFNβ mRNA and protein
were significantly upregulated. Immune cells, fibroblasts, and
endothelial cells residing in the tumor could exhibit differential DNA sensor upregulation, masking the DNA sensors activated in the tumor cells themselves.
In B16.F10 cells in vitro, IFNβ transcription, mRNA levels,
and protein levels were significantly elevated after pDNA electrotransfer but not after exposure to pDNA or electrotransfer
individually (Figure 3). The mRNAs for DDX60, p204, and

DAI were also significantly upregulated (Table 2). Other nonviral transfections also activate these sensors; several groups
used lipid transfection reagent in the original descriptions of
these DNA sensors32,33,39,40,48 and these sensors are activated
in other cell types by pDNA electrotransfer, such as C2C12
mouse myoblasts (data not shown). Each of these DNA sensors may induce the production of IFNβ when activated.32,33,35
DDX60 and DAI are exclusively cytosolic; IFI16, the human
ortholog of p204, is a nuclear sensor that moves to the cytosol after activation.49 The interesting observation that p204
mRNA is upregulated after pDNA electrotransfer may reflect
the quantity of pDNA that reaches the nucleus. Since pDNA
delivery to the nucleus is theoretically driven by endocytosis,22,23 this sensor may be activated by any successful
electrotransfer protocol to any cell type that expresses it.
A significant increase in DDX60 protein confirmed the mRNA
upregulation (Figure 2).

www.moleculartherapy.org/mtna
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Table 2 Fold changes in mRNA levels of DNA sensors in B16.F10 tumor cells 4 hours after pDNA electrotransfer
Control

N

EP

N

EP1

N

pDNA

N

EP+pDNA

N

EP1+pDNA

N

AIM2

ND

3

ND

3

ND

3

ND

3

ND

3

ND

3

cGAS

1.18 ± 0.18

5

0.65 ± 0.12

3

2.35 ± 0.15

3

1.67 ± 0.27

3

2.05 ± 0.62

5

DAI

0.95 ± 0.25

5

1.15 ± 0.58

3

2.94 ± 0.27

3

2.01 ± 0.18

3

228.14 ± 72.47*

5

256.86 ± 17.90*

6

DDX41

0.84 ± 0.16

3

0.66 ± 0.26

3

1.91 ± 0.11

3

1.21 ± 0.06

3

0.72 ± 0.07

3

1.60 ± 0.01*

3

DDX60

1.04 ± 0.10

9

1.00 ± 0.52

8

2.27 ± 0.44

3

1.44 ± 0.56

7

6.92 ± 1.85*

8

42.16 ± 5.36*

6

DHX9

1.12 ± 0.23

7

0.54 ± 0.14

4

1.82 ± 0.06

3

0.35 ± 0.13

4

0.86 ± 0.43

6

1.67 ± 0.64

3

DHX36

1.15 ± 0.24

7

0.46 ± 0.11

5

2.51 ± 0.83

3

0.54 ± 0.10

4

0.94 ± 0.39

6

0.86 ± 0.06

3

p202

ND

3

ND

3

ND

3

ND

3

ND

3

ND

3

p204

1.22 ± 0.70

2

5.45 ± 3.04

2

1.82 ± 0.24

3

1.23 ± 0.75

3

21.79 ± 5.85*

4

44.51 ± 7.40*

5

LRRFIP1

0.85 ± 0.16

3

0.62 ± 0.20

3

1.35 ± 0.36

3

0.85 ± 0.06

5

0.74 ± 0.12

5

0.62 ± 0.23

3

RIG-1

ND

6

ND

5

ND

3

ND

6

ND

8

ND

3

TLR9

ND

5

ND

3

ND

3

ND

2

ND

7

ND

3

Sensora

2.6 ± 0.24*

3

Control, 40 µl of cells and 10 µl of saline; EP, 40 µl of cells and 10 µl of saline were electroporated by the delivery of eight 5 ms pulses with a voltage-todistance ratio of 600 V/cm and frequency 1 Hz with a plate electrode; EP1, 40 µl of cells and 10 µl of saline were electroporated by the delivery of six 100 µs
pulses with a voltage-to-distance ratio of 1,300 V/cm and frequency 4 Hz with a plate electrode; pDNA, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid;
EP+pDNA, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid were electroporated by the delivery of eight 5 ms pulses with a voltage-to-distance ratio of
600 V/cm with a plate electrode; EP1+pDNA, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid were electroporated by the delivery of six 100 µs pulses
with a voltage-to-distance ratio of 1,300 V/cm and frequency 4 Hz with a plate electrode.
a
AIM2, absent in melanoma 2; cGAS, cyclic guanosine monophosphate-adenosine monophosphate synthase; DAI, DNA-dependent activator of interferon
regulatory factor; DDX41, DEAD (Asp-Glu-Ala-Asp) box polypeptide 41; DDX60, DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; DHX9, DEAH (Asp-Glu-Ala-His)
box helicase 9; DHX36, DEAH (Asp-Glu-Ala-His) box helicase 36; LRRFIP1; leucine-rich repeat flightless-interacting protein 1; RIG-1, retinoic acid inducible
gene upregulation of Type I interferon; TLR9, toll-like receptor 9. Mean ± SEM. *Statistically significant difference compared to all groups (P < 0.05).
ND, not detected.

Theoretically, the inhibition of endocytosis during electrotransfer could reduce gene expression by preventing entry of
pDNA into the cell or alternatively by driving pDNA delivery
to the cytosol. MβCD pretreatment doubled the upregulation
of IFNβ and DDX60 mRNA levels; however, DAI mRNA levels
significantly decreased (P < 0.05. Tables 2 and 3). These
discordant observations may support the possibility of differential distribution of DDX60 and DAI within the cytosol; after
electrotransfer accompanied by reduced endocytosis, pDNA
may be available to DDX60 but unavailable to DAI.
The cytosolic DNA sensors upregulated in our study are
activated by a variety of nucleic acids and possess overlapping downstream signaling pathways.28–31 DDX60 may bind
both RNA and DNA35 and play a cell type- and/or ligandspecific role.50,51 When stimulated by mammalian, bacterial, viral, and synthetic dsDNA, DAI mediates the induction
of proinflammatory molecules in a DNA dose-dependent
manner.32 Similar to this study, DAI protein was upregulated after challenge with herpes simplex virus type 1 in
glial cells52 and transcription was increased in hepatocellular carcinomas.53 After DNA electrotransfer to muscle,
mRNA levels increased.54 In vivo pDNA electrotransfer of
a plasmid encoding DAI acted as an adjuvant to a cancer
vaccine delivery in mice.55
Even though human IFI16 and mouse p204 share only
37% amino acid identity, both induce the production of IFNβ,
but not IL-1β, in several cell types in response to DNA.33
Interestingly, a fourfold increase in tumor IL-1β mRNA levels
after pDNA electrotransfer (P < 0.05, data not shown) was
not reflected in the B16.F10 cells in culture. This indicates
that other cell types found in tumors, possibly immune cells,
are also responding in vivo to pDNA electrotransfer. AIM2
and TLR9 mRNAs are detected in melanoma tumors but not
melanoma cells. This is not unexpected, since these proteins
are probably expressed in other cell types present in tumors.
Molecular Therapy—Nucleic Acids

Combined, these results indicate that the B16.F10 melanoma cells themselves produce IFNβ after pDNA electrotransfer, associated with the upregulation of multiple cytosolic
DNA sensors. Programmed necrosis may contribute to the
cell death observed in vitro, while both inflammation and
programmed necrosis may contribute to the in vivo antitumor effects in our study. DNA delivery by electroporation is a
common in vitro laboratory technique, and activation of DNA
sensors may be important to consider in specific research
areas. Since research utilizing in vivo pDNA electrotransfer is
often directed toward clinical applications, it is important and
significant to completely understand the underlying mechanisms involved.
The induction of inflammation may contribute to cancertargeted immune therapies. In a previous study of the antitumor effects of vector electrotransfer, 70% of B16.F10 tumors
completely regressed, and 70% of these tumor-free mice
were resistant to challenge with B16.F10 cells,7 indicating the
generation of an adaptive antitumor response. In a study of
intratumor electrotransfer of a plasmid encoding IL-12 in the
same tumor model, complete, long-term regression was produced in 89% of tumors.56 In this study, 100% of these mice
were resistant to challenge with the same tumor cell line.
A direct comparison is not possible since different plasmid
backbones and differing tumor-directed pulse parameters
were used in these studies; however, DNA sensor activation
may contribute to the effectiveness of IL-12 as an anticancer therapy. Indeed, type I interferon production is required
for the antitumor efficacy of a Semliki Forest virus encoding
IL-12 (ref. 57).
The induction of inflammation may also aid in the induction of immune responses to vaccines58 and can be beneficial in cancer gene therapies based on stimulation of immune
responses. However, therapies requiring simple transgene
expression may be inhibited when an immune response
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4
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a
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c

d

Fraction of cells normalized
to its pertinent control

Control

EP

EP1

EP+pDNA

EP1+pDNA

pDNA
EP+pDNA
EP1+pDNA

8

50 µm

6

2

0
Viable cells

Apoptotic cells
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Figure 3 Cell survival, transfection, cell death mechanism and morphology of B16.F10 cells after pDNA electrotransfer. Commercially
prepared vector plasmid (gWiz Blank) was electrotransferred into B16.F10 melanoma cells. Control, 40 µl of cells and 10 µl of saline; pDNA
1 mg/ml, 40 µl of cells and 10 µl of 1 mg/ml gWiz Blank plasmid; pDNA 2 mg/ml, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid; pDNA
3.5 mg/ml, 40 µl of cells and 10 µl of 3.5 mg/ml gWiz Blank plasmid; EP, 40 µl of cells and 10 µl of saline were electroporated by the delivery of
eight 5 ms pulses with a voltage-to-distance ratio of 600 V/cm with a plate electrode; EP+pDNA 1 mg/ml, 40 µl of cells and 10 µl of 1 mg/ml gWiz
Blank plasmid were electroporated as described in EP group; EP+pDNA 2 mg/ml, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid were
electroporated as described in EP group; EP+pDNA 3.5 mg/ml, 40 µl of cells and 10 µl of 3.5 mg/ml gWiz Blank plasmid were electroporated
as described in EP group; EP1, 40 µl of cells and 10 µl of saline were electroporated by the delivery of six 100 µs pulses with a voltage-todistance ratio of 1300 V/cm and frequency 4 Hz with a plate electrode; EP1+pDNA 1 mg/ml, 40 µl of cells and 10 µl of 1 mg/ml gWiz Blank
plasmid were electroporated as described in EP1 group; EP1+pDNA 2 mg/ml, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid were
electroporated as described in EP1 group; EP1+ pDNA 3.5 mg/ml, 40 µl of cells and 10 µl of 3.5 mg/ml gWiz Blank plasmid were electroporated
as described in EP1 group. For image B, 40 µl of cells and 10 µl of 2 mg/ml pEGFP-N1 plasmid were electroporated as previously described.
(a) Cell survival was measured 72 hours after electrotransfer and was normalized to the control group. (b) Transfection efficiency of B16.F10
cells after pEGFP-N1 electrotransfer after pDNA delivery with EP and EP1. *P < 0.05, statistically significant difference compared to all control
groups and EP only. a.u., arbitrary units. (c) Cell death mechanism as quantified by flow cytometery and (d) cell morphology after pDNA
electrotransfer. Blue arrows indicate necrotic cells displaying fragments of cytoplasm and only an outline of the nucleus. Black arrow indicates
apoptotic cells with vacuolization of the cytoplasm and formation of apoptotic bodies.
Table 3 Effect of the endocytosis inhibitor MβCD on fold changes in mRNA levels of IFNβ and DNA sensors in B16.F10 tumor cells 4 hours after DNA
electrotransfer
IFNβa

Control

N

EP

N

pDNA

N

EP+pDNA

N

1.26 ± 0.36

8

0.99 ± 0.29

6

2.78 ± 1.06

6

140.93 ± 56.31*

10

DNA sensorsb
DAI

1.05 ± 0.19

4

1.39 ± 0.99

2

1.10 ± 0.02

2

9.39 ± 2.88*

6

DDX60

1.04 ± 0.12

8

1.39 ± 0.36

6

8.52 ± 2.97

5

15.56 ± 2.21*

10

ND

4

ND

4

ND

4

ND

6

TLR9

All cells were fisrt incubated in MβCD for 30 minutes then divided into four delivery groups. Control, 40 µl of cells and 10 µl of saline; EP, 40 µl of cells and 10 µl
of saline were electroporated by the delivery of eight 5 ms pulses with a voltage-to-distance ratio of 600 V/cm and frequency 1 Hz with a plate electrode; pDNA,
40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid; EP+pDNA, 40 µl of cells and 10 µl of 2 mg/ml gWiz Blank plasmid were electroporated by the delivery of
eight 5 ms pulses with a voltage-to-distance ratio of 600 V/cm with a plate electrode.
a
IFNβ, interferon β. bDAI, DNA-dependent activator of interferon regulatory factor; DDX60, DEAD (Asp-Glu-Ala-Asp) box polypeptide 60; TLR9, toll-like receptor
9. Mean ± SE.
*Statistically significant difference compared to all groups (P < 0.05).
ND, not detected.
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is not desirable. To our knowledge, no pDNA electrotransfer gene therapy has been inhibited by the innate immune
response. However, this inhibition is a potential concern for
certain gene therapies.59 DNA sensor upregulation and subsequent activation of downstream signaling pathways should
be fully understood in order to harness or control it for therapeutic applications.
Materials and methods
Plasmids. gWiz Blank, an empty vector, and gWiz Luc, which
encodes the firefly luciferase gene driven by the CMV promoter, were commercially prepared (Aldevron, Fargo, ND).
The promoterless pGL3-Basic (Promega, Madison, WI) and
pGL3-IFNβ-prom, which encodes firefly luciferase driven
by the mouse IFNβ promoter, were kind gifts of Judith A.
Smith.60 These plasmids and pEGFP-N1 (BD Biosciences
Clontech, Palo Alto, CA), which encodes the enhanced green
fluorescent protein gene driven by the CMV promoter, were
prepared using Qiagen Maxi-Endo-Free Kits according to the
manufacturer’s instructions. All plasmids were suspended at
2 µg/µl in physiological saline unless otherwise noted.
Cells and tumors. All procedures were approved by the Veterinary Administration of The Ministry of Agriculture and the
Environment of the Republic of Slovenia (#34401–12/2009/6).
B16F.10 mouse melanoma cells (ATCC CRL-6475, American
Type Culture Collection, Manassas, VA) in the exponential growth
phase were used in experiments in vitro and in vivo. For tumor
induction, 1 × 106 B16.F10 melanoma cells in 50 µl phosphatebuffered saline (PBS) were injected subcutaneously in the left
flank of female 7–8-week-old C57Bl/6 mice (Envigo, Udine, Italy).
Tumors were allowed to grow approximately 8 days to a mean
tumor diameter of 4 mm before experiments were performed.
In vivo DNA electrotransfer. Mice were anesthetized using
a mixture of 2.5% isoflurane and 97.5% O2. Tumors were
injected with 50 µl of pDNA solution and eight square electric pulses with a voltage-to-distance ratio of 800 V/cm, a
pulse duration of 5 ms, and a frequency 1 Hz were delivered through two parallel stainless steel electrodes using an
Electro Cell B10 electric pulse generator (LEROY biotech,
L’Union, France). Tumors were measured twice to three times
weekly using a digital caliper. Tumor volume was calculated
by the formula v = ab2π/6, where a is the longest diameter,
and b is the next longest diameter perpendicular to a. Mice
were humanely euthanized when the tumor volume reached
1,000 mm3 or when the animal’s behavior indicated discomfort. Animals with tumors in regression were followed up to
100 days and were considered to be in complete regression if no tumor regrowth was observed during this time. For
postmortem tumor analysis, mice were humanely sacrificed,
tumors removed, and snap frozen on dry ice.
Real-time reverse transcription PCR. RNA was extracted
from tumors or cells 4 hours after electrotransfer using Trizol
Reagent (Invitrogen, Carlsbad, CA) then purified using
RNeasy columns (Qiagen, Valencia, CA). After extraction,
250 ng of total RNA was transcribed into cDNA using the
Molecular Therapy—Nucleic Acids

SuperScript VILO cDNA Synthesis Kit (Invitrogen, Thermo
Fisher Scientific,Waltham, MA). according to manufacturer’s instructions and diluted 10-fold. Messenger RNA was
quantified on a CFX96 Real Time PCR Detection System
(Bio-Rad, Hercules, CA) or a Primus 25 advanced thermal
cycler (Peqlab, Erlangen, Germany) using custom primers
(Integrated DNA Technologies, Coralville, IA) in SYBR Green
Master Mix (Applied Biosystems, Thermo Fisher Scientific
Waltham, MA). See Supplementary Table S1 for primer
sequences. Spleen RNA acted as a positive control. Relative
quantification was performed by comparison to the housekeeping genes β-actin and glyceraldehyde 3-phosphate
dehydrogenase using the ΔΔCt method.61
Protein quantification by ELISA. Tumors were homogenized
in PBS containing protease inhibitors and homogenates were
centrifuged to remove cell debris. bicinchoninic acid (BCA)
assays (Pierce Biotechnology, Rockford, IL) were performed
and samples normalized to 1 mg/ml total protein. ELISAs
were performed on the normalized homogenates per manufacturer’s instructions (PBL Assay Science, Piscataway, NJ).
Immunohistochemistry. Histological analysis was performed
at three different time points, 6, 20, and 36 hours. Three mice
from each experimental group were sacrificed in two independent experiments. The tumors were excised at selected time
point, fixed in immunohistochemistry (IHC) zinc fixative (BD
Pharmingen, BD Biosciences, San Jose, CA) overnight, and
embedded in paraffin. Consecutive 2-μm thick tumor sections
were cut from each paraffin block. The first section of each
tumor sample was stained with hematoxylin & eosin (H&E)
and analyzed. Based on H&E staining, the appropriate time
point for analysis of apoptosis was determined and following
tumor sections were stained with rabbit monoclonal antibodies against cleaved caspase-3 (Ca-3, Cell signaling Technology, Danvers, MA, dilution 1:1,500). A peroxidase-conjugated
streptavidin–biotin system (Rabbit-specific HRP/DAB detection IHC kit, ab64261, Abcam, Cambridge, England, UK)
was used as a colorogenic reagent followed by hematoxylin
counterstaining. The images of stained tumor sections were
captured with a DP72 CCD camera connected to a BX-51
microscope (Olympus, Hamburg, Germany). Whole tumor
sections were captured at ×4 magnification for H&E staining
and 5 images at ×60 magnification for Ca-3 staining. The percentage of tumor necrosis and the number of Ca-3-positive
cells were determined by two independent observers.
In vitro DNA electrotransfer. Trypsinized B16.F10 mouse
melanoma cells were suspended in electroporation buffer
and pDNA added as described previously.62 Aliquots were
transferred to cuvettes or pipetted between 2 mm gap steel
electrodes. Two different pulse types were used, eight square
wave electric pulses at an amplitude over distance ratio
600 V/cm, a pulse duration of 5 ms, and a frequency 1 Hz
(EP), and six square wave electric pulses at an amplitude
over distance ratio 1,300 V/cm, a pulse duration of 100 µs,
and a frequency of 4 Hz (EP1) electric pulses were generated by an in-house built electroporator (GT-01, Faculty of
Electrical Engineering, University of Ljubljana, Slovenia) or
with a T820 Electrosquare porator (BTX Molecular Delivery
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Systems, Holliston, MA). Cells were immediately diluted in
medium.
IFNβ transcription assay. Cells were transfected by DNA
electrotransfer with pGL3-Basic, pGL3-IFNβ-prom, or gWiz
Luc. After transfection, 2.5 × 105 cells in 100 µl medium per
well were incubated 16 hours in white opaque 96-well plates.
The medium was replaced with fresh medium containing
250 µg/ml luciferin and luciferase expression was immediately quantified (Lumistar Omega, BMG Labtech, Cary, NC).
The medium was again replaced with 100 µl medium containing PrestoBlue (Invitrogen, Thermo Fisher Scientific), incubated for 2 hours, and viability quantified as determined by
reducing ability (Gemini XPS, Molecular Devices, Sunnyvale,
CA). Luciferase expression was normalized to viability.
Protein detection by flow cytometry. Immunofluorescence
staining and subsequent flow cytometry analysis was performed for protein level quantification. Cells were collected
from 24-well ultra-low attachment plates 6 hours after electrotransfer. Cells were fixed in 4% paraformaldehyde (Alfa
Aesar, A Johnson Matthey Company, Ward Hill, MA) for
15 minutes, permeabilized with 0.5% Tween 20 (TWEEN
20, Sigma-Aldrich, Steinheim, DE) for 10 minutes and incubated in 10% donkey serum (Sigma-Aldrich) for 30 minutes.
Samples were incubated overnight at 4 °C with primary rabbit
anti-mouse polyclonal antibodies (Anti-DDX60, ab139807,
Abcam, dilution 1:100). Donkey anti-rabbit secondary
antibodies (Cy3 AffiniPure Donkey Anti-Rabbit IgG (H+L),
711-165-152, Jackson ImmunoResearch Laboratories, West
Grove, PA, dilution 1:150) were added and incubated for
1 hour. Cells were washed with PBS between each step. Measurements were performed with FACSCanto II flow cytometer (BD Biosciences, San Jose, CA) with appropriate filters
(excitation: 488 nm, emission: 530 nm). A histogram of cells
gated to eliminate debris against their fluorescence intensity
was recorded and the number of fluorescent cells and their
median fluorescence intensity were determined (software:
BD FACSDiva V6.1.2, BD Biosciences, San Jose, CA).
Protein detection by western blot. After performing assays at
4, 6, 9, and 20 hours after pDNA electrotransfer, the highest
expression of DDX60 was observed after 9 hours. Cells were
collected and washed with ice-cold PBS from 24-well ultra-low
attachment plates 9 hours after electrotransfer or trypsinyzed
from 6 cm Petri-dish plate 20 hours after electrotransfer. Cell
lysis was performed in radioimmuno precipitation assay lysis
buffer supplemented with protease and phosphatase inhibitors (Santa Cruz Biotechnology, Santa Cruz, CA) and incubated on ice for 30 minutes with constant mixing. Whole-cell
extracts were centrifuged and supernatants were collected.
BCA assays (Pierce Biotechnology, Rockford, IL) were used
for protein concentrations determination. A total of 25 µg of
total proteins from each sample was separated on NuPAGE
3–8% Tris-Acetate Midi-Gels for 35 minutes at 200 V using
NuPAGE Tris Acetate Sample Buffer and dry transferred to
a polyvinylidene fluoride membrane using iBlot Gel Transfer
Stack (Invitrogen, Thermo Fisher Scientific, Waltham). The
membranes were blocked with 5% low-fat dry milk (Pomurske
mlekarne, Murska Sobota, Slovenia) in Tris-buffered saline

(pH 7.4) containing 0.1% Tween-20 for 2 hours at room temperature and then incubated with primary rabbit anti-mouse
polyclonal antibodies, as listed in the section Protein detection by flow cytometry and β-actin (ab 75186, Abcam, dilution 1:1,000) as a loading control overnight at 4 °C. The next
day washed membranes were incubated with horseradish
peroxide-conjugated donkey anti-rabbit secondary antibody
for 45 minutes at room temperature. Protein bands were
detected with Image Quant LAS 4000 (GE Healthcare, Little
Chalfont, UK) after 5 minutes incubation of the membrane in
SuperSignal West Pico Chemiluminescent Substrate (Invitrogen, Thermo Fischer Scientific).
Cell survival assay. After electrotransfer of 1, 2, and 3.5 mg/
ml gWiz Blank plasmid, 1 × 103 cells were cultured in 100 µl of
medium in 96-well plates and incubated for 72 hours. Fresh
medium containing Presto Blue (Invitrogen, Carlsbad, CA)
was added to the cells and the fluorescence intensity was
measured by microplate reader (Infinite 200, Tecan, Männedorf, Switzerland) 30 minutes thereafter. Cell viability was
normalized to control group.
Proliferation assay. After electrotransfer, cells were cultured
in 6 cm Petri dishes for 16 hours to recover. Viable B16F10
cells (2.5 × 102) were cultured in 100 µl of medium in 96-well
plates for the proliferation assay. A Presto Blue assay was
performed 2, 48, and 96 hours after viable cell culture
according to manufacturer’s instructions. Cell proliferation in
each experimental group was normalized to day 0 for that
group. A second normalization to the untreated control group
at day 4 was performed to determine percentage of reduced
proliferation.
Determination of cell death mechanism. Cell death mechanisms were determined 20 hours after pDNA electrotransfer
using a FITC Annexin V Apoptosis Detection Kit with 7-AAD
(7-amino-actinomycin D, BioLegend, San Diego, CA) according to manufacturer’s instructions. A FACSCanto II flow
cytometer (BD Biosciences, San Jose, CA), with a 488-nm
laser (air-cooled, 20 mW solid state) was used for the excitation and both 530 and 650-nm band-pass filter were used for
detection of green and red fluorescence.
Cell morphology. For morphological observation of cells,
cytospins were prepared. For each sample, a labeled slide,
chamber and blotter were prepared and assembled. Six hours
after pDNA electrotranfer, 80 µl of 1 × 103 B16.F10 cells
were added to a slide chamber and spun at 1,000 rpm for
4 minutes in a cytocentrifuge (Cytospin 2, Thermo Shandon,
Runcorn, UK). The slides were air dried then stained with
Giemsa’s Azure methylene blue solution (Merck, Germany)
according to the manufacturer’s protocol. Cell images were
captured with a DP72 CCD camera connected to a BX-51
microscope.
Endocytosis inhibition. Cells were trypsinized and counted.
4.5 × 106 B16F10 cells were incubated 30 minutes in 3.75 ml
of medium containing 7.5 mmol/l methyl-β cyclodextrin
(MβCD). Fifteen milliliters of electroporation buffer were
added then cells were centrifuged and resuspended in 44 µl
www.moleculartherapy.org/mtna
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of ice-cold electroporation buffer. 11 µl of 2 µg/µl gWiz Blank
were added. 50 µl of the mixture was electroporated and total
RNA was extracted for further analysis as described above.
Transfection efficiency. One day after pDNA electrotransfer,
transfection efficiency was determined by fluorescent microscopy and quantified by flow cytometry. Three different observation fields of bright-field and fluorescent (exposure 400 ms)
images of the cells were captured at ×100 objective magnification with Olympus IX-70 (Hamburg, Germany) and appropriate filters (excitation: 460–490 nm, emission: 505 nm). The
same samples were later trypsinized and resuspended in
400 µl of phosphate-buffered saline for flow cytometry analysis. Flow cytometry was performed as previously described.
Statistical analysis. For graphical representation and statistical analysis, SigmaPlot Software (Systat Software, Chicago,
IL) was used. The data were first tested for normality of distribution with the Shapiro-Wilk test. The differences between
the experimental groups were statistically evaluated by oneway analysis of variance followed by a Holm-Sidak test for
multiple comparison. A P value of less than 0.05 was considered to be statistically significant.
Supplementary material
Figure S1. The presence of inflammatory immune cells in
melanoma tumor after pDNA electrotransfer.
Figure S2. Cell death mechanisms asdetermined by flow
cytometry(FITC Annexin V Apoptosis Detection Kit with
7-AAD, BioLegend, San Diego, CA, USA).
Table S1. Primers used in this study.
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